125 related articles for article (PubMed ID: 9067501)
1. Plasma levels of soluble E-selectin in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1997 Mar; 54(3):219-24. PubMed ID: 9067501
[TBL] [Abstract][Full Text] [Related]
2. Soluble E-selectin, interleukin-6 and tissue factor in two cases of meningococcal septicaemia.
Roldán V; Marín F; Blann A
Blood Coagul Fibrinolysis; 2004 Mar; 15(2):179-82. PubMed ID: 15091005
[TBL] [Abstract][Full Text] [Related]
3. Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation.
Gando S; Kameue T; Matsuda N; Hayakawa M; Hoshino H; Kato H
Thromb Res; 2005; 116(2):91-100. PubMed ID: 15907522
[TBL] [Abstract][Full Text] [Related]
4. Plasma level of tumor necrosis factor in disseminated intravascular coagulation.
Wada H; Ohiwa M; Kaneko T; Tamaki S; Tanigawa M; Takagi M; Mori Y; Shirakawa S
Am J Hematol; 1991 Jul; 37(3):147-51. PubMed ID: 1858767
[TBL] [Abstract][Full Text] [Related]
5. Plasma level of IL-1 beta in disseminated intravascular coagulation.
Wada H; Tamaki S; Tanigawa M; Takagi M; Mori Y; Deguchi A; Katayama N; Yamamoto T; Deguchi K; Shirakawa S
Thromb Haemost; 1991 Apr; 65(4):364-8. PubMed ID: 2057918
[TBL] [Abstract][Full Text] [Related]
6. Increased plasma level of interleukin-6 in disseminated intravascular coagulation.
Wada H; Tanigawa M; Wakita Y; Nakase T; Minamikawa K; Kaneko T; Ohiwa M; Kageyama S; Kobayashi T; Noguchi T
Blood Coagul Fibrinolysis; 1993 Aug; 4(4):583-90. PubMed ID: 8218855
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Am J Hematol; 1991 Dec; 38(4):281-7. PubMed ID: 1660674
[TBL] [Abstract][Full Text] [Related]
8. Biomarker Profile of Sepsis-Associated Coagulopathy Using Biochip Assay for Inflammatory Cytokines.
Walborn A; Hoppensteadt D; Syed D; Mosier M; Fareed J
Clin Appl Thromb Hemost; 2018 May; 24(4):625-632. PubMed ID: 28514870
[TBL] [Abstract][Full Text] [Related]
9. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation.
Wada H; Ohiwa M; Kaneko T; Tamaki S; Tanigawa M; Shirakawa S; Koyama M; Hayashi T; Suzuki K
Am J Hematol; 1992 Jan; 39(1):20-4. PubMed ID: 1311143
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
Mosad E; Elsayh KI; Eltayeb AA
Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
[TBL] [Abstract][Full Text] [Related]
11. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation.
Madoiwa S; Nunomiya S; Ono T; Shintani Y; Ohmori T; Mimuro J; Sakata Y
Int J Hematol; 2006 Dec; 84(5):398-405. PubMed ID: 17189219
[TBL] [Abstract][Full Text] [Related]
13. Management of cancer-associated disseminated intravascular coagulation.
Levi M
Thromb Res; 2016 Apr; 140 Suppl 1():S66-70. PubMed ID: 27067981
[TBL] [Abstract][Full Text] [Related]
14. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of granulocyte elastase-alpha 1-proteinase inhibitor complex in patients with disseminated intravascular coagulation: pathophysiologic implications.
Okajima K; Fujise R; Motosato Y; Ushijima M; Okabe H; Takatsuki K
Am J Hematol; 1994 Oct; 47(2):82-8. PubMed ID: 8092145
[TBL] [Abstract][Full Text] [Related]
16. [Elevated levels of cytokines in plasma from patients with disseminated intravascular coagulation].
Wada H; Tamaki S; Tanigawa M; Takagi M; Iwasaki E; Mori Y; Deguchi A; Tsukada T; Kageyama S; Kobayashi T
Rinsho Ketsueki; 1990 Oct; 31(10):1622-5. PubMed ID: 2255053
[TBL] [Abstract][Full Text] [Related]
17. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
[TBL] [Abstract][Full Text] [Related]
18. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
Taylor FB; Wada H; Kinasewitz G
Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
[TBL] [Abstract][Full Text] [Related]
19. Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis.
Ikeda M; Matsumoto H; Ogura H; Hirose T; Shimizu K; Yamamoto K; Maruyama I; Shimazu T
J Crit Care; 2018 Feb; 43():48-53. PubMed ID: 28843664
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases.
Okajima K; Sakamoto Y; Uchiba M
Am J Hematol; 2000 Nov; 65(3):215-22. PubMed ID: 11074538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
